ImmunoPrecise Antibodies Ltd. (IPA)
IPA has a market cap or net worth of $37.58 million. The enterprise value is $44.54 million.
The next confirmed earnings date is Thursday, December 14, 2023, before market open.
|Earnings Date||Dec 14, 2023|
IPA has 25.05 million shares outstanding. The number of shares has increased by 1.26% in one year.
|Shares Change (YoY)||+1.26%|
|Shares Change (QoQ)||+0.08%|
|Owned by Insiders (%)||1.70%|
|Owned by Institutions (%)||6.51%|
|EV / Earnings||n/a|
|EV / Sales||2.71|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 2.45, with a Debt / Equity ratio of 0.18.
|Debt / Equity||0.18|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -35.40% and return on invested capital (ROIC) is -35.59%.
|Return on Equity (ROE)||-35.40%|
|Return on Assets (ROA)||-26.00%|
|Return on Capital (ROIC)||-35.59%|
|Revenue Per Employee||$160,903|
|Profits Per Employee||-$154,070|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -67.50% in the last 52 weeks. The beta is 0.51, so IPA's price volatility has been lower than the market average.
|52-Week Price Change||-67.50%|
|50-Day Moving Average||1.60|
|200-Day Moving Average||2.55|
|Relative Strength Index (RSI)||54.76|
|Average Volume (30 Days)||64,941|
Short Selling Information
The latest short interest is 29,009, so 0.12% of the outstanding shares have been sold short.
|Short Previous Month||47,035|
|Short % of Shares Out||0.12%|
|Short % of Float||0.13%|
|Short Ratio (days to cover)||0.30|
In the last 12 months, IPA had revenue of $16.41 million and -$15.72 million in losses. Loss per share was -$0.62.
|Loss Per Share||-$0.62|
The company has $5.01 million in cash and $7.21 million in debt, giving a net cash position of -$2.21 million or -$0.09 per share.
|Cash & Cash Equivalents||5.01M|
|Net Cash Per Share||-$0.09|
|Equity / Book Value||39.57M|
|Book Value Per Share||1.58|
In the last 12 months, operating cash flow was -$7.51 million and capital expenditures -$1.13 million, giving a free cash flow of -$8.65 million.
|Operating Cash Flow||-7.51M|
|Free Cash Flow||-8.65M|
|FCF Per Share||-$0.35|
Gross margin is 53.19%, with operating and profit margins of -101.45% and -95.75%.
Dividends & Yields
IPA does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The average price target for IPA is $8.00, which is 433.33% higher than the current price. The consensus rating is "Strong Buy".
|Price Target Difference||433.33%|
|Analyst Consensus||Strong Buy|
|Revenue Growth Forecast (5Y)||18.39%|
|EPS Growth Forecast (5Y)||n/a|
The last stock split was on November 23, 2020. It was a reverse split with a ratio of 1:5.
|Last Split Date||Nov 23, 2020|
IPA has an Altman Z-Score of -0.38 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.